Human papillomavirus (HPV) infection is very prevalent. It occurs early, most of the times after onset of sexual activity. Among diseases associated with HPV infection, cervical cancer stands out. It continues to affect many women worldwide, especially in developing countries like Brazil, even though screening programs are effective when organized. The knowledge about genetic structure of different HPV types and the technological evolution provided vaccines development to prevent infection by oncogenic and non oncogenic HPV types.
Since 2007, HPV vaccines have been administered to adolescents in Immunization Programs around the world. They promote prevention of HPV cervical cancer and clinical lesions. In this target group, mainly between 9 and 12 years old, there is no concerns about vaccine safety and effectiveness. (,)
[…]
Search
Search in:
Comments